Re-Cognition Health | Guildford, United Kingdom

Research site

Site insights

Top conditions

Parent organization

This site is a part of Re-Cognition Health

Data sourced from

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 1 total trial

Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

The purpose of this study is to compare the efficacy and safety of daily and every other day dosing of rimegepant to placebo as a preventive treatmen...

Active, not recruiting
Drug: Placebo comparator dosing
Drug: Rimegepant 75mg every other day dosing

Trial sponsors

Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems